Defining the needs for next generation assays for tuberculosis

Claudia M. Denkinger, Sandra V. Kik, Daniela M aria Cirillo, Martina Casenghi, Thomas Shinnick, Karin Weyer, Chris Gilpin, Catharina C. Boehme, Marco Schito, Michael Kimerling, Madhukar Pai

Research output: Contribution to journalArticle

Abstract

To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics that are more accurate and can be used closer to where patients first seek care in affordable diagnostic algorithms. This article describes the efforts by the stakeholder community that led to the identification of the high-priority diagnostic needs in tuberculosis. Subsequently target product profiles for the high-priority diagnostic needs were developed and reviewed in a World Health Organization (WHO)-led consensus meeting. The high-priority diagnostic needs included (1) a sputum-based replacement test for smear-microscopy; (2) a non-sputum-based biomarker test for all forms of tuberculosis, ideally suitable for use at levels below microscopy centers; (3) a simple, low cost triage test for use by first-contact care providers as a rule-out test, ideally suitable for use by community health workers; and (4) a rapid drug susceptibility test for use at the microscopy center level. The developed target product profiles, along with complimentary work presented in this supplement, will help to facilitate the interaction between the tuberculosis community and the diagnostics industry with the goal to lead the way toward the post-2015 global tuberculosis targets.

Original languageEnglish
Pages (from-to)S29-S38
JournalJournal of Infectious Diseases
Volume211
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Tuberculosis
Microscopy
Triage
Sputum
Industry
Biomarkers
Costs and Cost Analysis
Pharmaceutical Preparations

Keywords

  • diagnosis
  • point-of-care
  • prioritization
  • target product profiles
  • tuberculosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Denkinger, C. M., Kik, S. V., Cirillo, D. M. A., Casenghi, M., Shinnick, T., Weyer, K., ... Pai, M. (2015). Defining the needs for next generation assays for tuberculosis. Journal of Infectious Diseases, 211, S29-S38. https://doi.org/10.1093/infdis/jiu821

Defining the needs for next generation assays for tuberculosis. / Denkinger, Claudia M.; Kik, Sandra V.; Cirillo, Daniela M aria; Casenghi, Martina; Shinnick, Thomas; Weyer, Karin; Gilpin, Chris; Boehme, Catharina C.; Schito, Marco; Kimerling, Michael; Pai, Madhukar.

In: Journal of Infectious Diseases, Vol. 211, 01.04.2015, p. S29-S38.

Research output: Contribution to journalArticle

Denkinger, CM, Kik, SV, Cirillo, DMA, Casenghi, M, Shinnick, T, Weyer, K, Gilpin, C, Boehme, CC, Schito, M, Kimerling, M & Pai, M 2015, 'Defining the needs for next generation assays for tuberculosis', Journal of Infectious Diseases, vol. 211, pp. S29-S38. https://doi.org/10.1093/infdis/jiu821
Denkinger, Claudia M. ; Kik, Sandra V. ; Cirillo, Daniela M aria ; Casenghi, Martina ; Shinnick, Thomas ; Weyer, Karin ; Gilpin, Chris ; Boehme, Catharina C. ; Schito, Marco ; Kimerling, Michael ; Pai, Madhukar. / Defining the needs for next generation assays for tuberculosis. In: Journal of Infectious Diseases. 2015 ; Vol. 211. pp. S29-S38.
@article{5aafc6d6962a4d4f9f3cccd171a989ad,
title = "Defining the needs for next generation assays for tuberculosis",
abstract = "To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics that are more accurate and can be used closer to where patients first seek care in affordable diagnostic algorithms. This article describes the efforts by the stakeholder community that led to the identification of the high-priority diagnostic needs in tuberculosis. Subsequently target product profiles for the high-priority diagnostic needs were developed and reviewed in a World Health Organization (WHO)-led consensus meeting. The high-priority diagnostic needs included (1) a sputum-based replacement test for smear-microscopy; (2) a non-sputum-based biomarker test for all forms of tuberculosis, ideally suitable for use at levels below microscopy centers; (3) a simple, low cost triage test for use by first-contact care providers as a rule-out test, ideally suitable for use by community health workers; and (4) a rapid drug susceptibility test for use at the microscopy center level. The developed target product profiles, along with complimentary work presented in this supplement, will help to facilitate the interaction between the tuberculosis community and the diagnostics industry with the goal to lead the way toward the post-2015 global tuberculosis targets.",
keywords = "diagnosis, point-of-care, prioritization, target product profiles, tuberculosis",
author = "Denkinger, {Claudia M.} and Kik, {Sandra V.} and Cirillo, {Daniela M aria} and Martina Casenghi and Thomas Shinnick and Karin Weyer and Chris Gilpin and Boehme, {Catharina C.} and Marco Schito and Michael Kimerling and Madhukar Pai",
year = "2015",
month = "4",
day = "1",
doi = "10.1093/infdis/jiu821",
language = "English",
volume = "211",
pages = "S29--S38",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Defining the needs for next generation assays for tuberculosis

AU - Denkinger, Claudia M.

AU - Kik, Sandra V.

AU - Cirillo, Daniela M aria

AU - Casenghi, Martina

AU - Shinnick, Thomas

AU - Weyer, Karin

AU - Gilpin, Chris

AU - Boehme, Catharina C.

AU - Schito, Marco

AU - Kimerling, Michael

AU - Pai, Madhukar

PY - 2015/4/1

Y1 - 2015/4/1

N2 - To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics that are more accurate and can be used closer to where patients first seek care in affordable diagnostic algorithms. This article describes the efforts by the stakeholder community that led to the identification of the high-priority diagnostic needs in tuberculosis. Subsequently target product profiles for the high-priority diagnostic needs were developed and reviewed in a World Health Organization (WHO)-led consensus meeting. The high-priority diagnostic needs included (1) a sputum-based replacement test for smear-microscopy; (2) a non-sputum-based biomarker test for all forms of tuberculosis, ideally suitable for use at levels below microscopy centers; (3) a simple, low cost triage test for use by first-contact care providers as a rule-out test, ideally suitable for use by community health workers; and (4) a rapid drug susceptibility test for use at the microscopy center level. The developed target product profiles, along with complimentary work presented in this supplement, will help to facilitate the interaction between the tuberculosis community and the diagnostics industry with the goal to lead the way toward the post-2015 global tuberculosis targets.

AB - To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics that are more accurate and can be used closer to where patients first seek care in affordable diagnostic algorithms. This article describes the efforts by the stakeholder community that led to the identification of the high-priority diagnostic needs in tuberculosis. Subsequently target product profiles for the high-priority diagnostic needs were developed and reviewed in a World Health Organization (WHO)-led consensus meeting. The high-priority diagnostic needs included (1) a sputum-based replacement test for smear-microscopy; (2) a non-sputum-based biomarker test for all forms of tuberculosis, ideally suitable for use at levels below microscopy centers; (3) a simple, low cost triage test for use by first-contact care providers as a rule-out test, ideally suitable for use by community health workers; and (4) a rapid drug susceptibility test for use at the microscopy center level. The developed target product profiles, along with complimentary work presented in this supplement, will help to facilitate the interaction between the tuberculosis community and the diagnostics industry with the goal to lead the way toward the post-2015 global tuberculosis targets.

KW - diagnosis

KW - point-of-care

KW - prioritization

KW - target product profiles

KW - tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84929994231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929994231&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiu821

DO - 10.1093/infdis/jiu821

M3 - Article

C2 - 25765104

AN - SCOPUS:84929994231

VL - 211

SP - S29-S38

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

ER -